← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Glc Biotechnology, Inc.
Solon, OH
$7,781,341
Total funding
9
Grants
Funding over time
peak $1.1M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,781,341 · 9
By mechanism
R44$6,861,341 · 4
R43$920,000 · 5
Investigators at Glc Biotechnology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of An Innovative TEE Technology for Mutation Detection$1,071,571
R44 · FY2023 · CA
Development of An Innovative TEE Technology for Mutation Detection$928,164
R44 · FY2024 · CA
MMPA: A Novel Multiplexing Methylation Analysis Technology$906,540
R44 · FY2010 · CA
MMPA: A Novel Multiplexing Methylation Analysis Technology$892,755
R44 · FY2009 · CA
A Novel Method for Efficiently and Robustly Retrieving Circulating miRNAs$750,000
R44 · FY2019 · GM
A Novel Method for Efficiently and Robustly Retrieving Circulating miRNAs$750,000
R44 · FY2020 · GM
Surveying the Status of a Large Number of Mutations by A Single PEPD Assay$704,760
R44 · FY2006 · CA
Surveying the Status of a Large Number of Mutations by A Single PEPD Assay$638,201
R44 · FY2007 · CA
Fecal DNA Testing for Colorectal cancer Screening$225,000
R43 · FY2014 · CA
A Method for Quantitatively Retrieving Circulating miRNAs from Plasma$225,000
R43 · FY2016 · GM
Development of a novel liquid biopsy test to assist targeted MSI-H cancer treatment$225,000
R43 · FY2018 · CA
MMPA: A Novel Multiplexing Methylation Analysis Technology$219,350
R44 · FY2008 · CA
A Novel Technology for Capturing Fecal HUMAN DNA$145,000
R43 · FY2006 · CA
Molecular Haplotyping of Long Genomic Distances of DNA$100,000
R43 · FY2004 · HG